Form 4: Boston Scientific Executive Sells Shares in Recent Transaction

Emily Woodworth, a Senior Vice President at Boston Scientific, sold 1,336 shares of common stock at an average price of $90.6476 on November 27, 2024.

Summary

• Emily Woodworth, a Senior Vice President at Boston Scientific, sold 1,336 shares of the company's common stock on November 27, 2024.
• The shares were sold at a weighted average price of $90.6476 per share.
• The sale was executed in multiple transactions with prices ranging from $90.6202 to $90.6538.
• Following the transaction, Ms. Woodworth directly owns 2,957 shares of Boston Scientific common stock.
• This total includes shares acquired on June 30, 2024, under the company's Employee Stock Purchase Plan.

Sentiment

Score: 5

Explanation: The document is a neutral report of a routine stock sale by an executive, with no indication of positive or negative sentiment.

Industry Context

This is a routine Form 4 filing, which is common for corporate executives who trade their company's stock. It provides transparency into insider transactions.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the United States.
• Executives at comparable medical device companies such as Medtronic and Abbott also regularly file Form 4s when they trade their company's stock.
• The volume of shares sold is relatively small compared to the total outstanding shares of Boston Scientific, suggesting this is a personal transaction rather than a significant market event.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on shareholders, employees, customers, suppliers, or creditors due to the small volume of shares sold.

Key Dates

Keywords

Boston Scientific, stock sale, insider trading, executive transaction, common stock, Emily Woodworth